Th17及Treg相关因子在反复种植失败患者种植窗口期子宫内膜中的表达
2016-12-03艾海权腊晓琳巩晓芸李霞朱玥洁丁剑冰玛依热吐尔逊
艾海权,腊晓琳,巩晓芸,李霞,朱玥洁,丁剑冰,玛依热·吐尔逊*
(1. 新疆医科大学第一附属医院妇科生殖助孕中心生殖医学科,乌鲁木齐 830054;2. 新疆医科大学基础医学院免疫教研室,乌鲁木齐 830011)
Th17及Treg相关因子在反复种植失败患者种植窗口期子宫内膜中的表达
艾海权1,腊晓琳1,巩晓芸1,李霞1,朱玥洁1,丁剑冰2,玛依热·吐尔逊1*
(1. 新疆医科大学第一附属医院妇科生殖助孕中心生殖医学科,乌鲁木齐 830054;2. 新疆医科大学基础医学院免疫教研室,乌鲁木齐 830011)
目的 通过研究种植窗口期子宫内膜中Treg及Th17特异性转录因子及相关细胞因子表达情况,探讨反复种植失败患者子宫内膜中Treg/Th17平衡调节的可能机制。 方法 建立种植窗口期子宫内膜标本库。从标本库选择2013年10月至2014年12月收集的符合实验要求的反复种植失败患者(实验组)及首次移植妊娠患者(对照组)各20例,采用定量RT-PCR测量内膜标本中的Treg、Th17特异性表达因子Foxp3和ROR-γt及相关细胞因子IL-10、IL-17表达情况。 结果 在实验组和对照组子宫内膜上均可见Foxp3、ROR-γt及细胞因子IL-10、IL-17表达;与对照组比较,实验组Foxp3 mRNA的相对表达量[(0.77±0.15) vs.(1.57±1.22)]及IL-10 mRNA的相对表达量[(1.14±1.03) vs.(1.54±1.77)]均显著降低(P<0.05),而ROR-γt mRNA的相对表达量[(0.92±0.39) vs.(0.55±0.15)]及IL-17 mRNA的相对表达量[(0.95±0.31) vs.(0.49±0.21)]均显著升高(P<0.05)。 结论 IL-17、IL-10可能参与内膜中Th17/Treg平衡调节。
Treg; Th17; 反复种植失败; 子宫内膜容受性; 种植窗
Methods:The endometrial specimens bank in the implantation window phase was established. A total of 40 specimens met the experimental requirements were collected from October 2013 to December 2014. Among them,20 specimens were from the patients with repeated implantation failure as experimental group,and another 20 specimens from the pregnancy patients in their first transplantation as the control group. The expressions of Foxp3,ROR-γt,IL-10,and IL-17 in endometrial specimens were measured by quantitative RT-PCR.
Results:Foxp3,ROR-γt,IL-10,and IL-17 in endometrium were expressed in both experimental group and control group. The mRNA expressions of Foxp3(0.77 ± 0.15 vs. 1.57 ± 1.22)and IL-10(1.14 ± 1.03 vs. 1.54 ± 1.77)in the experimental group were significantly lower than those in the control group (P<0.05). The mRNA expressions of ROR-γt(0.92 ± 0.39 vs. 0.55 ± 0.15)and IL-17(0.95 ± 0.31 vs. 0.49 ± 0.21) in the experimental group were significantly higher than those in the control group (P<0.05).
Conclusions:IL-10 and IL-17 may involve in regulation balance of Th17/Treg.
(JReprodMed2016,25(11):1013-1017)
不孕症严重影响患者的身心健康,己成为一个重要的医学和社会问题。辅助生殖技术(ART)为不孕症治疗开辟了新篇章,随着这一技术及其衍生技术的飞速发展,治疗周期中获得优质胚胎的数量增多,但临床妊娠率却始终徘徊在40%~70%,而且胚胎种植率一直波动于25%~35%之间。胚胎种植失败成为辅助生殖治疗失败的最大原因。……
